MedPath

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Not Applicable
Completed
Conditions
Androgenetic Alopecia
Registration Number
NCT06149221
Lead Sponsor
Dr. Peter C. Friedman
Brief Summary

In-office applied non-thermal atmospheric pressure plasma treatment on NS pretreated scalp

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • diagnosis of mild-to moderate androgenetic alopecia
  • ability to keep in-person follow-up appointments
Exclusion Criteria
  • any inflammatory scalp condition
  • starting or discontinuing any hair loss treatments within 6 months of start date
  • allergy to any components of the carrier solution

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Presence of detectable hair growth3 months and 6 months

Presence of hair growth as measured using the HairMetrix device

Secondary Outcome Measures
NameTimeMethod
Adverse effects related to the treatmentthroughout study completeion, 6 months

Patients are monitored for adverse effects, including but not limited to irritation, itch, inflammation, scaling, redness, rash, peeling, blistering

Trial Locations

Locations (1)

The Skin Center Dermatology Group

πŸ‡ΊπŸ‡Έ

New City, New York, United States

The Skin Center Dermatology Group
πŸ‡ΊπŸ‡ΈNew City, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.